Optimus Healthcare Svcs Inc Financials
This page shows Optimus Healthcare Svcs Inc (OHCS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
High gross margins are being swallowed by cash-funded overhead, leaving day-to-day operations reliant on external financing.
Across FY2021-FY2023, operating cash burn totaled about-$10.5M while financing inflows totaled about$10.3M . Because new capital mostly replaced cash consumed by operations rather than building assets, cash still ended FY2023 at only$100K and liquidity fell to a 0.1x current ratio. That is the pattern of a company funding continuity, not accumulating operating capacity.
The striking mix in FY2023 is gross margin above
Balance-sheet erosion has been faster than revenue growth: assets shrank from
Financial Health Signals
We are recalculating Optimus Healthcare Svcs Inc's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Optimus Healthcare Svcs Inc passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
Key Financial Metrics
Earnings & Revenue
Optimus Healthcare Svcs Inc generated $1.5M in revenue in fiscal year 2023. This represents an increase of 22.9% from the prior year.
Optimus Healthcare Svcs Inc earned $-0.28 per diluted share (EPS) in fiscal year 2023. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
Optimus Healthcare Svcs Inc held $100K in cash against $0 in long-term debt as of fiscal year 2023.
Optimus Healthcare Svcs Inc had 40M shares outstanding in fiscal year 2023. This represents an increase of 4.4% from the prior year.
Margins & Returns
Optimus Healthcare Svcs Inc's gross margin was 81.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is up 2.6 percentage points from the prior year.
Capital Allocation
Optimus Healthcare Svcs Inc spent $137K on share buybacks in fiscal year 2023, returning capital to shareholders by reducing shares outstanding.
OHCS Income Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $385K-39.8% | $639K+85.6% | $344K-23.5% | $450K-0.8% | $454K+40.7% | $322K+18.7% | $272K+24.6% | $218K |
| Cost of Revenue | $74K+27.6% | $58K-6.6% | $62K-5.0% | $65K-17.9% | $80K+34.8% | $59K-26.1% | $80K+31.6% | $61K |
| Gross Profit | $311K-46.5% | $581K+105.9% | $282K-26.6% | $385K+2.8% | $374K+42.1% | $263K+37.4% | $192K+22.0% | $157K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $448K+2.4% | $437K+25.1% | $350K-47.2% | $662K+40.0% | $473K-21.3% | $601K+40.8% | $427K-26.4% | $580K |
| Operating Income | -$1.6M-28.2% | -$1.2M-343.8% | $512K | N/A | -$1.3M+44.5% | -$2.4M+9.4% | -$2.7M-974.9% | $306K |
| Interest Expense | $205K+1.8% | $202K+4.4% | $193K-23.1% | $251K+73.7% | $144K+25.9% | $115K+10.6% | $104K+2.4% | $101K |
| Income Tax | N/A | $993+5941.2% | -$17 | N/A | N/A | $2K | N/A | N/A |
| Net Income | -$1.8M-24.5% | -$1.5M-242.6% | -$423K | N/A | -$1.8M+37.8% | -$2.9M+3.2% | -$3.0M-1371.0% | -$201K |
| EPS (Diluted) | $-0.04-33.3% | $-0.03-200.0% | $-0.01 | N/A | $-0.04+42.9% | $-0.070.0% | $-0.07 | N/A |
OHCS Balance Sheet
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $630K-27.1% | $863K+5.2% | $820K-23.4% | $1.1M-54.5% | $2.3M+9.9% | $2.1M-16.8% | $2.6M-12.5% | $2.9M |
| Current Assets | $418K-34.1% | $634K+10.7% | $573K-28.9% | $807K-27.6% | $1.1M+17.7% | $946K-31.3% | $1.4M-20.2% | $1.7M |
| Cash & Equivalents | $152K+1093.6% | $13K-82.2% | $72K-28.7% | $100K-49.9% | $200K+1.6% | $197K-11.1% | $222K-70.5% | $751K |
| Inventory | N/A | N/A | N/A | N/A | $7K | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | $816K0.0% | $816K0.0% | $816K0.0% | $816K |
| Total Liabilities | $10.0M+4.8% | $9.5M+5.1% | $9.1M+10.3% | $8.2M+9.3% | $7.5M+17.3% | $6.4M+27.5% | $5.0M+9.7% | $4.6M |
| Current Liabilities | $9.8M+5.0% | $9.4M+5.4% | $8.9M+10.7% | $8.0M+10.7% | $7.3M+17.9% | $6.2M+260.1% | $1.7M+11.5% | $1.5M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$9.3M-7.9% | -$8.7M-5.1% | -$8.2M-15.3% | -$7.1M-38.3% | -$5.2M-21.0% | -$4.3M-73.9% | -$2.5M-49.4% | -$1.6M |
| Retained Earnings | -$33.8M-5.6% | -$32.0M-4.7% | -$30.6M-1.4% | -$30.1M-13.2% | -$26.6M-7.2% | -$24.8M-13.0% | -$22.0M-15.5% | -$19.0M |
OHCS Cash Flow Statement
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $84K+135.1% | -$239K-88.0% | -$127K+75.5% | -$518K+41.1% | -$879K+15.4% | -$1.0M+17.0% | -$1.3M-24.6% | -$1.0M |
| Capital Expenditures | N/A | N/A | N/A | N/A | $16K | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | -$895K | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | $1+100.0% | -$16K | N/A | N/A | -$128K |
| Financing Cash Flow | $56K-69.0% | $180K+83.2% | $98K-76.5% | $418K-53.5% | $898K+10.7% | $811K+12.2% | $722K-39.9% | $1.2M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | $0 | $0 | N/A | N/A | N/A |
OHCS Financial Ratios
| Metric | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 80.8%-10.2pp | 90.9%+9.0pp | 82.0%-3.5pp | 85.5%+3.0pp | 82.4%+0.8pp | 81.7%+11.1pp | 70.5%-1.5pp | 72.1% |
| Operating Margin | -416.2%-220.8pp | -195.4%-344.2pp | 148.8% | N/A | -296.7%+456.1pp | -752.8%+233.9pp | -986.7%-1127.3pp | 140.6% |
| Net Margin | -469.5%-242.5pp | -227.0%-104.0pp | -122.9% | N/A | -391.9%+495.3pp | -887.2%+200.5pp | -1087.6%-995.5pp | -92.2% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -287.0%-118.8pp | -168.1%-116.5pp | -51.6% | N/A | -75.7%+58.1pp | -133.8%-18.8pp | -114.9%-108.1pp | -6.8% |
| Current Ratio | 0.04-0.0 | 0.070.0 | 0.06-0.0 | 0.10-0.1 | 0.150.0 | 0.15-0.7 | 0.81-0.3 | 1.13 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | -197.2% | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$7.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.10), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Optimus Healthcare Svcs Inc's annual revenue?
Optimus Healthcare Svcs Inc (OHCS) reported $1.5M in total revenue for fiscal year 2023. This represents a 22.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Optimus Healthcare Svcs Inc's revenue growing?
Optimus Healthcare Svcs Inc (OHCS) revenue grew by 22.9% year-over-year, from $1.2M to $1.5M in fiscal year 2023.
What is Optimus Healthcare Svcs Inc's gross margin?
Optimus Healthcare Svcs Inc (OHCS) had a gross margin of 81.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.
What is Optimus Healthcare Svcs Inc's operating cash flow?
Optimus Healthcare Svcs Inc (OHCS) generated -$3.7M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.
What are Optimus Healthcare Svcs Inc's total assets?
Optimus Healthcare Svcs Inc (OHCS) had $1.1M in total assets as of fiscal year 2023, including both current and long-term assets.
What is Optimus Healthcare Svcs Inc's current ratio?
Optimus Healthcare Svcs Inc (OHCS) had a current ratio of 0.10 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is Optimus Healthcare Svcs Inc's cash runway?
Based on fiscal year 2023 data, Optimus Healthcare Svcs Inc (OHCS) had $100K in cash against an annual operating cash burn of $3.7M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Optimus Healthcare Svcs Inc's debt-to-equity ratio negative or not reported?
Optimus Healthcare Svcs Inc (OHCS) has negative shareholder equity of -$7.1M as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Optimus Healthcare Svcs Inc's Piotroski F-Score?
Optimus Healthcare Svcs Inc (OHCS) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.